Rasburicase biosimilar - Virchow GroupAlternative Names: Tuly
Latest Information Update: 23 May 2015
At a glance
- Originator Virchow Group
- Class Antigouts; Oxidoreductases
- Mechanism of Action Urate oxidase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Hyperuricaemia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated